“The compound SR-17018 is the 1st biased agonist on the mu opioid receptor that does not result in tolerance with chronic use,” suggests Stahl, a senior staff members scientist while in the Bohn lab. “It is a desirable feature for opportunity use from the context of Persistent, severe agony.” https://9royalstreet.com/product/sr-17018-vendor/